- Clinician perspectives on current issues in lung cancer drug development. Journal of Thoracic Oncology. 2016 Review GET IT
Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: A multicentre, open-label, phase 2 trial.
International Journal of Molecular Sciences.
Times cited: 50